Literature DB >> 24375276

Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.

Nathaniel D Lambert1, Iana H Haralambieva, Inna G Ovsyannikova, Beth R Larrabee, V Shane Pankratz, Gregory A Poland.   

Abstract

Although vaccination campaigns have significantly reduced the global burden of rubella disease, there are still regional outbreaks and cases of congenital rubella syndrome. Rubella vaccination elicits a strong humoral as well as cellular response. The relationship between these two measures in response to rubella vaccine is poorly understood. We have previously reported no correlation between rubella-virus-specific cytokine secretion and IgG antibody levels after rubella vaccination. In the current study, we extend our previous work to report correlations between secreted cytokines and functional neutralizing antibodies after rubella vaccination in four distinct cohorts. There was evidence of significant differences (p < 0.05) in rubella-virus-specific humoral and cellular responses between cohorts. When investigating relationships between rubella-vaccine-specific humoral and cellular immunity, we observed a significant correlation between neutralizing antibodies and IFN-γ (r(s) = 0.21, p = 0.0004). We also observed correlations in subjects with extreme humoral immune phenotypes and IFN-γ levels in two of the four cohorts (r(s) = 0.32, p = 0.01; r(s) = 0.36, p = 0.01, respectively). These findings indicate that there is a high level of heterogeneity in rubella-specific immune responses between study populations. We believe that the novel correlation discovered between IFN-γ and neutralizing antibody titers will give future insight into the functional mechanisms of immunity induced by rubella virus and other live viral vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24375276      PMCID: PMC4212652          DOI: 10.1007/s12026-013-8475-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  46 in total

1.  Twin studies of immunogenicity--determining the genetic contribution to vaccine failure.

Authors:  P L Tan; R M Jacobson; G A Poland; S J Jacobsen; V S Pankratz
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

Review 2.  Immunologic correlates of protection induced by vaccination.

Authors:  S A Plotkin
Journal:  Pediatr Infect Dis J       Date:  2001-01       Impact factor: 2.129

3.  The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Hum Hered       Date:  2011-11-11       Impact factor: 0.444

4.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-25       Impact factor: 3.641

5.  Ongoing outbreak of rubella among young male adults in Poland: increased risk of congenital rubella infections.

Authors:  I Paradowska-Stankiewicz; M P Czarkowski; T Derrough; P Stefanoff
Journal:  Euro Surveill       Date:  2013-05-23

6.  Small rise in rubella cases triggers warning.

Authors:  Jacqui Wise
Journal:  BMJ       Date:  2013-05-07

7.  IFN-gamma represses IL-4 expression via IRF-1 and IRF-2.

Authors:  Bernd Elser; Michael Lohoff; Sonja Kock; Marco Giaisi; Sabine Kirchhoff; Peter H Krammer; Min Li-Weber
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

8.  Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Gene       Date:  2012-08-23       Impact factor: 3.688

9.  Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination.

Authors:  Iana H Haralambieva; Ann L Oberg; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Sumit Middha; Brian M Bot; Vivian W Wang; David I Smith; Robert M Jacobson; Gregory A Poland
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

10.  Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.

Authors:  Alexander L Pukhalsky; Galina V Shmarina; Maria S Bliacher; Irina M Fedorova; Anna P Toptygina; Julia J Fisenko; Vladimir A Alioshkin
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

View more
  12 in total

1.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

2.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

3.  Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.

Authors:  Nathaniel D Lambert; Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Vernon Shane Pankratz; Gregory A Poland
Journal:  J Infect Dis       Date:  2014-10-06       Impact factor: 5.226

4.  Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-08-21       Impact factor: 2.846

5.  Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Krista M Goergen; Diane E Grill; Min-Hsin Chen; Lijuan Hao; Joseph Icenogle; Gregory A Poland
Journal:  Vaccine       Date:  2019-11-12       Impact factor: 3.641

6.  Lessons learned in the analysis of high-dimensional data in vaccinomics.

Authors:  Ann L Oberg; Brett A McKinney; Daniel J Schaid; V Shane Pankratz; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2015-05-06       Impact factor: 3.641

7.  Durability of humoral immune responses to rubella following MMR vaccination.

Authors:  Stephen N Crooke; Marguerite M Riggenbach; Inna G Ovsyannikova; Nathaniel D Warner; Min-Hsin Chen; Lijuan Hao; Joseph P Icenogle; Gregory A Poland; Richard B Kennedy
Journal:  Vaccine       Date:  2020-11-12       Impact factor: 3.641

8.  Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2015-09-02       Impact factor: 2.846

9.  Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.

Authors:  Stephen N Crooke; Inna G Ovsyannikova; Richard B Kennedy; Nathaniel D Warner; Gregory A Poland
Journal:  Vaccine       Date:  2020-11-04       Impact factor: 3.641

10.  Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts.

Authors:  Iana H Haralambieva; Hannah M Salk; Nathaniel D Lambert; Inna G Ovsyannikova; Richard B Kennedy; Nathaniel D Warner; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2014-02-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.